Como evitar a formação de substâncias tóxicas durante a absorção de dióxido de carbono pela cal sodada com uso de anestésicos halogenados
Preventing toxic substances production during carbon dioxide absorption by soda lime with halogenate anesthetics
Renato Ângelo Saraiva
Resumo
Palavras-chave
Abstract
Keywords
Referencias
Wilson RE. Sodalime absorbent for industrial purposes. Ind Eng Chem. 1920;12:1000-1006.
Waters RM. Clinical scope and utility of carbon dioxide filtration with inhalation anesthesia. Anesth Analg. 1924;3:20-28.
Waters RM. Advantages and techniques of carbon dioxide filtration with inhalation anesthesia. Anesth Analg. 1926;5:160-166.
Adriani J. The Effect of the varying of moisture content of soda lime upon the efficiency of carbon dioxide absorption. Anesthesiology. 1945;6:163-171.
Adriani J. Disposal of carbon dioxide from devices used for inhalation anesthesia. Anesthesiology. 1944;6:35-52.
Adriani J, Batten DH. The efficiency of moisture of barium and calcium hydroxides in the absorption of CO2 rebreathing appliances. Anesthesiology. 1945;6:35-52.
Adriani J. Soda lime containing indicators. Anesthesiology. 1944;5:45-53.
Hale DE. The rise and fall of soda lime. Anesth Analg. 1967;46:648-655.
Adriani J. Rebreathing in anesthesia. South Med J. 1942;35:798-804.
Grodin WK, Epstein MA, Epstein RA. Mechanisms of halothane adsorption by dry soda-lime. Br J Anaesth. 1982;54:561-565.
Strum DP, Jonson BH, Eger II EI. Stability of sevoflurane in soda lime. Anesthesiology. 1987;67:779-781.
Lin J, Laster MJ, Eger II EI. Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit. Anesth Analg. 1991;72:785-789.
Frink Jr EJ, Malan TP, Morgan SE. Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients. Anesthesiology. 1992;77:1064-1069.
Fang ZX, Eger II EI. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and baralyme in a standard anesthetic circuit. Anesth Analg. 1995;81:564-568.
Hanaki C, Fuji K, Morio M. Decomposition of sevoflurane by sodalime. Hiroshima J Med Sci. 1987;36:61-67.
Brown ES, Bakamjian V, Seniff AM. Performance of absorbents: effect of moisture. Anesthesiology. 1959;20:613-617.
Eger II EI, Strum DP. The absorption and degradation of isoflurane and I-653 by dry soda lime at various temperatures. Anesth Analg. 1987;66:1312-1315.
Strum DP, Eger II EI. The degradation, absorption and solubility of volatile anesthetics in soda lime depend on water content. Anesth Analg. 1994;78:340-348.
Fang ZX, Eger II EI, Laster MJ. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and baralyme. Anesth Analg. 1995;80:1187-1193.
Harrison N, Knowles AC, Welchew EA. Carbon monoxide within circle systems. Anaesthesia. 1996;51:1037-1040.
Wissing H, Kuhn I, Warnken U. Carbon monoxide production from desflurane, enflurane, halothane, isoflurane, and sevoflurane with dry soda lime. Anesthesiology. 2001;95:1205-1212.
Braum J, Sitte T, Straub JM. Die reaction on sevoflurane mettrickenem atemkalk: Uberlegungen anlablich eines aktuellen zwischen falls. Anasth Intesivmed. 1998;39:11-16.
Narkool DM, Kirkpaltric JN. Treatment of acute carbon monoxide poising with hyperbaric oxygen: A review of 115 cases. Ann Emerg Med. 1985;14:1168-1182.
Frink Jr EJ, Nogami WM, Morgan SE. High carboxyhemoglobin concentrations occur in swine during desflurane anesthesia in presence of partially dried carbon dioxide absorbents. Anesthesiology. 1997;87:308-316.
Goldberg ME, Cantillo J, Gratz I. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg. 1999;88:437-445.
Neumann MA, Laster MJ, Weiskopf RB. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane do carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg. 1999;89:768-773.